Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T12:45:15.918Z.
Calculation as of: 2026-10-06T12:45:15.918Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
ADARx Pharmaceuticals, Inc.
Market Cap
$1.95B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
EV/EBITDA Ratio
10.51x
TTM Avg
10.14x
3Y Avg
23.25x
5Y Avg
17.80x
Market Cap
$2.03B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.03B
EV/EBITDA Ratio
22.11x
TTM Avg
17.81x
3Y Avg
11.61x
5Y Avg
9.67x
Market Cap
$1.86B
EV/EBITDA Ratio
12.34x
TTM Avg
13.82x
3Y Avg
15.92x
5Y Avg
18.35x
Market Cap
$2.05B
EV/EBITDA Ratio
9.25x
TTM Avg
8.34x
3Y Avg
7.32x
5Y Avg
6.62x
Market Cap
$2.10B
EV/EBITDA Ratio
11.66x
TTM Avg
11.92x
3Y Avg
11.13x
5Y Avg
12.34x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | $1.95B | N/A | N/A | N/A | N/A |
| Allient Inc. (ALNT)vs › | $2.02B | 28.95x | 19.97x | 14.15x | 14.15x |
| Allegiant Travel Company (ALGT)vs › | $2.02B | 10.51x | 10.14x | 23.25x | 17.80x |
| Arxis, Inc. Class A Common Stock (ARXS)vs › | $2.03B | N/A | N/A | N/A | N/A |
| Preformed Line Products Company (PLPC)vs › | $2.03B | 22.11x | 17.81x | 11.61x | 9.67x |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.86B | 12.34x | 13.82x | 15.92x | 18.35x |
| Cimpress plc (CMPR)vs › | $1.85B | 8.17x | 9.06x | 9.45x | 11.56x |
| Werner Enterprises, Inc. (WERN)vs › | $2.05B | 9.25x | 8.34x | 7.32x | 6.62x |
| Trinity Industries, Inc. (TRN)vs › | $2.10B | 11.66x | 11.92x | 11.13x | 12.34x |
| Hub Group, Inc. (HUBG)vs › | $1.74B | 6.72x | 8.97x | 8.20x | 7.39x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
